Medicare expands free PAD screening to prevent amputations in at-risk seniors
H.R. 307 — ARC Act of 2025 · Filed by LaMonica McIver (D-NJ) · 44 cosponsors · Introduced Jan 9, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires Medicare and Medicaid to cover peripheral artery disease (PAD) screening tests for at-risk beneficiaries without cost-sharing (copays, coinsurance, deductibles). It defines at-risk groups (seniors 65+, people 50–64 with atherosclerosis risk factors, younger people with diabetes plus another risk factor, and those with known arterial disease elsewhere). The bill also funds a CDC education program, establishes quality measures to reduce amputations, and creates a pilot program testing amputation-prevention services at hospitals.
Why we flagged it
The bill's core mechanism is a straightforward Medicare/Medicaid coverage mandate for PAD screening without cost-sharing, paired with education and quality-improvement initiatives. It is a public-health measure, not a tax provision, subsidy, or deregulation.
What the text implies
- The bill defines 'at-risk beneficiary' broadly enough to potentially cover millions of Medicare/Medicaid enrollees, creating an open-ended federal coverage obligation with no explicit spending cap or sunset.
- The Secretary retains discretion to expand the definition of 'peripheral artery disease screening test' to include 'such other items and services as [the Secretary] determines…to be appropriate,' potentially broadening coverage beyond the named tests (ankle-brachial index, arterial duplex scans).
- Quality measures tied to amputation prevention may create financial incentives for providers to perform PAD screening and treatment, potentially driving up utilization and costs if the screening-to-treatment pipeline is not carefully managed.
- The pilot program (Section 6) authorizes testing of 'voluntary' amputation-prevention programs, but the text does not specify how 'voluntary' is defined or whether participation will be tracked for cost-effectiveness.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
At-risk beneficiaries gain access to preventive screening without cost barriers, potentially reducing amputations and deaths—particularly among minorities who face disproportionate amputation rates. The bill removes financial obstacles to early detection of a serious, often-silent disease. No offsetting cost to beneficiaries or the general public is apparent from the text.
Who stands to gain
- diagnostic imaging providers (ultrasound, duplex scan facilities)
- vascular surgeons and interventional radiologists
- hospital outpatient departments
- ambulatory surgical centers
- diagnostic equipment manufacturers (ultrasound, ABI devices)
Named in the bill
Centers for Disease Control and Prevention (CDC), Centers for Medicare & Medicaid Services (CMS), Health Resources and Services Administration (HRSA), Medicare (Title XVIII, Social Security Act), Medicaid (Title XIX, Social Security Act), Center for Medicare and Medicaid Innovation (CMMI), Merit-Based Incentive Payment System (MIPS), Shared Savings Program
Where it stands
44 cosponsors: 41 Democrats, 3 Republicans.
- Jan 9, 2025 — Introduced · Congress.gov: “Introduced in House”
- Jan 9, 2025 — Referred to House Committee on Ways and Means and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
15 lobbying clients named this bill on 28 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $896,000 in lobbying spend. A filing names 2 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 95% of bills with at least one filing.
LaMonica McIver, the sponsor, reported $575,550 in PAC receipts in the 2026 cycle.
- American College of Cardiology — $680,000 on 1 filing
- Cardiovascular Coalition — $120,000 on 1 filing
- Association of Black Cardiologists — $60,000 on 2 filings
- Society for Cardiovascular Angiography and Interventions — $36,000 on 1 filing
- American Vascular Access, LLC (cardiovascular Coalition) — $0 on 2 filings
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (14,278 characters) on Aug 20, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Dec 2025 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“Medicare expands free PAD screening to prevent amputations in at-risk seniors” QuorumCivic. https://share.quorumcivic.app/bill/119/hr307 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.